Illumina, Glaxo Pen SNP-Marker Collaboration | GenomeWeb

NEW YORK, Sept. 19 - Illumina and GlaxoSmithKline will turn a "large" set of SNP markers into SNP assays that Illumina will use to create a whole-genome linkage disequilibrium-mapping product to be deployed with its BeadArray platform, the companies said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.